Douglass Winthrop Advisors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $858K | Hold |
1,600
| – | – | 0.02% | 150 |
|
2025
Q1 | $672K | Hold |
1,600
| – | – | 0.01% | 165 |
|
2024
Q4 | $662K | Hold |
1,600
| – | – | 0.01% | 176 |
|
2024
Q3 | $808K | Hold |
1,600
| – | – | 0.02% | 163 |
|
2024
Q2 | $780K | Hold |
1,600
| – | – | 0.02% | 155 |
|
2024
Q1 | $864K | Hold |
1,600
| – | – | 0.02% | 146 |
|
2023
Q4 | $867K | Hold |
1,600
| – | – | 0.02% | 130 |
|
2023
Q3 | $700K | Hold |
1,600
| – | – | 0.02% | 137 |
|
2023
Q2 | $804K | Hold |
1,600
| – | – | 0.02% | 137 |
|
2023
Q1 | $800K | Sell |
1,600
-93
| -5% | -$46.5K | 0.02% | 132 |
|
2022
Q4 | $691K | Hold |
1,693
| – | – | 0.02% | 147 |
|
2022
Q3 | $552K | Hold |
1,693
| – | – | 0.02% | 156 |
|
2022
Q2 | $594K | Sell |
1,693
-1,507
| -47% | -$529K | 0.02% | 158 |
|
2022
Q1 | $1.75M | Sell |
3,200
-2,700
| -46% | -$1.48M | 0.04% | 109 |
|
2021
Q4 | $3.89M | Hold |
5,900
| – | – | 0.09% | 83 |
|
2021
Q3 | $3.67M | Buy |
5,900
+31
| +0.5% | +$19.3K | 0.09% | 81 |
|
2021
Q2 | $3.71M | Buy |
5,869
+62
| +1% | +$39.2K | 0.09% | 78 |
|
2021
Q1 | $2.84M | Sell |
5,807
-2,000
| -26% | -$978K | 0.08% | 89 |
|
2020
Q4 | $3.9M | Hold |
7,807
| – | – | 0.11% | 63 |
|
2020
Q3 | $3.07M | Hold |
7,807
| – | – | 0.1% | 67 |
|
2020
Q2 | $2.58M | Hold |
7,807
| – | – | 0.1% | 72 |
|
2020
Q1 | $1.89M | Hold |
7,807
| – | – | 0.08% | 80 |
|
2019
Q4 | $2.04M | Hold |
7,807
| – | – | 0.07% | 92 |
|
2019
Q3 | $2.12M | Sell |
7,807
-3,222
| -29% | -$876K | 0.08% | 87 |
|
2019
Q2 | $3.04M | Buy |
+11,029
| New | +$3.04M | 0.12% | 76 |
|